Axonics Modulation Technologies, Inc.
https://www.axonics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Axonics Modulation Technologies, Inc.
Medtronic Beats Back Axonics’ Challenge To InterStim Patents
The US patent office has upheld all seven patents at issue, with the verdict on the final three having come on 22 September.
Medtronic ‘Plays Offense’ Despite Pandemic Challenges, Q1 Results Provide Optimism
Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.
Win For Axonics As England’s NICE Says Rechargeable Neuromodulation Is Cost-Effective
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.
Global Approvals Snapshot: November 2019
November’s approvals include the US FDA approval of Medtronic’s In.Pact AV paclitaxel-coated balloon, for the treatment of arteriovenous access in patients with end-stage renal disease, and a CE mark that expands the indication for Edwards’ Sapien 3 TAVR device to include patients at low-risk during surgery.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Contura Limited